These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9300663)

  • 1. RNA processing and clinical variability in neurofibromatosis type I (NF1).
    Skuse GR; Cappione AJ
    Hum Mol Genet; 1997; 6(10):1707-12. PubMed ID: 9300663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.
    Cappione AJ; French BL; Skuse GR
    Am J Hum Genet; 1997 Feb; 60(2):305-12. PubMed ID: 9012403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
    Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
    Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
    Scheurlen WG; Senf L
    Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1 (NF1) gene: implication in neuroectodermal differentiation and genesis of brain tumors.
    Nishi T; Saya H
    Cancer Metastasis Rev; 1991 Dec; 10(4):301-10. PubMed ID: 1786631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
    Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
    Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of the neurofibromatosis type 1 protein product.
    DeClue JE; Cohen BD; Lowy DR
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1.
    Assunto A; Ferrara U; De Luca A; Pivonello C; Lombardo L; Piscitelli A; Tortora C; Pinna V; Daniele P; Pivonello R; Russo MG; Limongelli G; Colao A; Tartaglia M; Strisciuglio P; Melis D
    Orphanet J Rare Dis; 2019 Nov; 14(1):261. PubMed ID: 31730495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
    Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
    Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of neurofibromatosis type 1].
    Suzuki H; Takahashi K; Shibahara S
    Nihon Rinsho; 1993 Sep; 51(9):2457-61. PubMed ID: 8411728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
    Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H
    Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
    Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
    Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of the neurofibromatosis type I pre-mRNA.
    Barron VA; Lou H
    Biosci Rep; 2012 Apr; 32(2):131-8. PubMed ID: 22115364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of NF1 transcripts reveals novel highly expressed splice variants.
    Vandenbroucke I; Vandesompele J; De Paepe A; Messiaen L
    FEBS Lett; 2002 Jul; 522(1-3):71-6. PubMed ID: 12095621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.
    Nakafuku M; Nagamine M; Ohtoshi A; Tanaka K; Toh-e A; Kaziro Y
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6706-10. PubMed ID: 8341688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex.
    Arun V; Wiley JC; Kaur H; Kaplan DR; Guha A
    J Neurosci Res; 2013 Apr; 91(4):494-505. PubMed ID: 23361976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in the 3' untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression.
    Cowley GS; Murthy AE; Parry DM; Schneider G; Korf B; Upadhyaya M; Harper P; MacCollin M; Bernards A; Gusella JF
    Somat Cell Mol Genet; 1998 Mar; 24(2):107-19. PubMed ID: 9919310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.